Adani gives final approval for coal mine project in Australia

June 6, 2017

Melbourne, Jun 6: Indian conglomerate Adani Group todaygave the final investment approval for its controversy- hit 21.7billion dollars Carmichael coal mine project in Australia which had hit several roadblocks over environmental concerns due to its proximity to the Great Barrier Reef.adani

"I am proud to announcethe project has Final Investment Decision (FID) approvalwhich marksthe official start of one of the largest singleinfrastructure-- and job creating -- developments in Australia's recent history," Adani Group Chairman Gautam Adani said.

This is a historic day for Adani, a historic day for regional Queensland, andahistoric day for the Indian investment in Australia, he said.

The announcement comes just days after the Adani Group agreed to pay royalties on coal produced from its project after it struck an agreement with the Queensland government to help the controversy-hit project move forward.

"Thisisthe largest single investment by an Indian corporation in Australia, andI believeotherswill followwithinvestments and trade deals," the Adani Group Chairman said.

"We have been challengedby activists in the courts, ininner citystreets,and even outside banks thathave noteven been approachedto financetheproject. We are still facingactivists. But we are committed to this project," Adani said, adding that the group is committed to Queenslandand to addressing energy poverty in India.

Adani said the Carmichael projects will generate 10,000 direct and indirect jobs,with pre-construction works starting in the September Quarter 2017.

Queensland Premier Annastacia Palaszczuk today officially opened Adani's Regional Headquarters (RHQ) in Townsville fromwhere the companywill oversee theconstruction and operations of theproject.

The regional headquarters will also accommodate Adani's Remote Operations Centre, the first time that such a centre has been set up in an Australian regional city.

PrimeMinister Malcolm Turnbullwas represented at the ceremony bythe Federal Minister for Northern Australia and Resources, Senator Matt Canavan.

Adani Australia Head of Country and Chief Executive Jeyakumar Janakaraj saidthe companyhasalready invested 3.3 billion dollars in the project, including buying the bulk coal handling port ofAbbot Point.

Adani today also signed letters of awardfordesign, construction, operations, the supply ofmaterialsandprofessional services.

The biggestdealis withDownerMiningfor the construction and operation of the Carmichael mine.

The company hasalso announced in the past few weeks contracts totalling more than 150 million dollars for the railway tracks and concrete sleepers for the planned388- kmstandard gaugerail link between the mine and Abbot Point.

Importantly, these contracts had gone to regional cities to generate jobs -- 74 million dollars for railway tracks (Arrium Steel, Whyalla) and 82 million dollars for sleepers (Austrak, Rockhampton).

Janakaraj also announcedanother contract for the CarmichaelRail Network linkingGalilee Basinmines, including the Adani mine,tothe port ofAbbot Point.

This contract iswith AECOM,who are regionally based in Townsville.

The AECOM deal coverssurveying anddesignfor the rail linkwith the company basing 70 people in Townsville.

"But we are building more than a rail line," Janakaraj said.

"We are building a line that will open the Galilee Basin, linking that massive coal reserve to markets around the world, generating power, and -- importantly -- generating many thousands of direct and indirect jobs in regional Queensland," Janakaraj said.

In Adani's case, it will linkitsCarmichael coal mine to its bulk loading facility atthe port ofAbbot Point from where it will be shipped to Adani's power stations in India. While some may be looking for ways to leave regional Queensland, Adani is looking to the future, he said.

"We are looking to ensure regional Queensland remains a great place to live, work and to raise a family. To achieve that, Adani is delivering onitspromise to address power poverty for hundreds of millions in India and unacceptably high unemployment in regional Queensland," he added.

"To those activists who sit in creature comfort and criticise us, I ask a simple question -- what are you doing for those people?" Janakaraj said.

Meanwhile, a group of religious leaders camped out today at the Sydney-based Commonwealth Bank's headquarters to protest against the proposed Adani mega coal mine project.

Local media reported that ten Buddhist and Christian leaders rallied outside the Darling Harbour office, holding signs with messages including 'People of faith say rule out Adani' and 'Grandpa what did you do about global warming?'

Uniting Church Minister Rex Graham said the group was opposed to the expansion of coal mines in Australia.

"The other banks have heard the message, particularly National Australian Bank and Westpac, and that's what we're looking for the Commonwealth Bank to also do so," he was quoted as saying.

The Carmichael coal project, Australia's largest, has been delayed since first being proposed in 2010 due to protests by green groups over its environmental impact.

The Indian energy giant has for more than five years battled the opposition to any expansion of the Abbot Point port, saying it will cut into the Great Barrier Reef World Heritage Area.

The project involves dredging 1.1 million cubic metres of soil near the Great Barrier Reef Marine Park, which will then be disposed of on land.

The Adani Group entered Australia in 2010 with the purchase of the greenfield Carmichael coal mine in the Galilee Basin in central Queensland, and the Abbot Point port near Bowen in the north.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 24,2020

Paris, Apr 24: The worldwide death toll from the coronavirus pandemic crossed 190,000 on Friday, with nearly two-thirds of the fatalities in Europe, according to an AFP tally compiled from official sources at 0740 GMT.

A total of 190,089 people have died and 2,698,733 been infected since the virus emerged in China in December. The hardest hit continent is Europe, with 116,221 deaths and 1,296,248 cases.

The country with the most deaths is the United States with 49,963, followed by Italy with 25,549, Spain with 22,157, France with 21,856 and Britain 18,738.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 8,2020

Washington, Mar 8: An attendee at last week's Conservative Political Action Conference (CPAC), which also saw the participation of US President Donald Trump, has tested positive for COVID-19, the American Conservative Union (ACU) said.

The exposure occurred prior to the conference held in National Harbor, Maryland, just south of Washington D.C., Xinhua news agency quoted the ACU as saying in a statement on Saturday.

A New Jersey hospital tested the person, and the Centers for Disease Control and Prevention (CDC) confirmed the positive result, said the statement.

"The individual is under the care of medical professionals in the state of New Jersey, and has been quarantined," it said.

Trump and Vice President Mike Pence spoke at the gathering, which took place from February 26-29.

Also present at the event were a number of administration and cabinet officials, including Secretary of State Mike Pompeo, Health and Human Services Secretary Alex Azar, and newly-appointed White House Chief of Staff Mark Meadows.

White House Press Secretary Stephanie Grisham said in a statement Saturday that the White House was aware of the development.

"At this time there is no indication that either President Trump or Vice President Pence met with or were in close proximity to the attendee," Grisham said in a statement.

"The President's physician and US Secret Service have been working closely with White House Staff and various agencies to ensure every precaution is taken to keep the First Family and the entire White House Complex safe and healthy."

The news emerged as Washington D.C. and neighbouring state of Virginia respectively confirmed their first cases of COVID-19 on Saturday.

In a press conference on Saturday night, Washington D.C. Mayor Muriel Bowser said a resident in his 50s showed symptoms of a respiratory virus in February. He was admitted to a hospital in the District on March 5.

The patient had no history of recent international travel, nor had he been exposed to anyone who was confirmed to be infected, according to Bowser.

The Mayor said D.C. health authorities were investigating the man's contact with other people before he went to the hospital.

A US Marine assigned to Fort Belvoir in Fairfax County, Virginia, tested positive on Saturday for COVID-19 and is currently being treated at Fort Belvoir Community Hospital, according to a Pentagon spokesman.

"The Marine recently returned from overseas where he was on official business," tweeted Jonathan Rath Hoffman, adding that Secretary of Defence Mark Esper and the White House have been briefed.

As of Saturday night, more than 420 cases of COVID-19 were reported in the US with 17 deaths, according to the Center for Systems Science and Engineering at Johns Hopkins University.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 19,2020

May 19: A Chinese laboratory has been developing a drug it believes has the power to bring the coronavirus pandemic to a halt.

The outbreak first emerged in China late last year before spreading across the world, prompting an international race to find treatments and vaccines.

A drug being tested by scientists at China's prestigious Peking University could not only shorten the recovery time for those infected, but even offer short-term immunity from the virus, researchers say.

Sunney Xie, director of the university's Beijing Advanced Innovation Center for Genomics, told AFP that the drug has been successful at the animal testing stage.

"When we injected neutralising antibodies into infected mice, after five days the viral load was reduced by a factor of 2,500," said Xie.

"That means this potential drug has (a) therapeutic effect."

The drug uses neutralising antibodies -- produced by the human immune system to prevent the virus infecting cells -- which Xie's team isolated from the blood of 60 recovered patients.

A study on the team's research, published Sunday in the scientific journal Cell, suggests that using the antibodies provides a potential "cure" for the disease and shortens recovery time.

Xie said his team had been working "day and night" searching for the antibody.

"Our expertise is single-cell genomics rather than immunology or virology. When we realised that the single-cell genomic approach can effectively find the neutralising antibody we were thrilled."

He added that the drug should be ready for use later this year and in time for any potential winter outbreak of the virus, which has infected 4.8 million people around the world and killed more than 315,000.

"Planning for the clinical trial is underway," said Xie, adding it will be carried out in Australia and other countries since cases have dwindled in China, offering fewer human guinea pigs for testing.

"The hope is these neutralised antibodies can become a specialised drug that would stop the pandemic," he said.

China already has five potential coronavirus vaccines at the human trial stage, a health official said last week.

But the World Health Organization has warned that developing a vaccine could take 12 to 18 months.

Scientists have also pointed to the potential benefits of plasma -- a blood fluid -- from recovered individuals who have developed antibodies to the virus enabling the body's defences to attack it.

More than 700 patients have received plasma therapy in China, a process which authorities said showed "very good therapeutic effects".

"However, it (plasma) is limited in supply," Xie said, noting that the 14 neutralising antibodies used in their drug could be put into mass production quickly.

Using antibodies in drug treatments is not a new approach, and it has been successful in treating several other viruses such as HIV, Ebola and Middle East Respiratory Syndrome (MERS).

Xie said his researchers had "an early start" since the outbreak started in China before spreading to other countries.

Ebola drug Remdesivir was considered a hopeful early treatment for COVID-19 -- clinical trials in the US showed it shortened the recovery time in some patients by a third -- but the difference in mortality rate was not significant.

The new drug could even offer short-term protection against the virus.

The study showed that if the neutralising antibody was injected before the mice were infected with the virus, the mice stayed free of infection and no virus was detected.

This may offer temporary protection for medical workers for a few weeks, which Xie said they are hoping to "extend to a few months".

More than 100 vaccines for COVID-19 are in the works globally, but as the process of vaccine development is more demanding, Xie is hoping that the new drug could be a faster and more efficient way to stop the global march of the coronavirus.

"We would be able to stop the pandemic with an effective drug, even without a vaccine," he said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.